Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
Open Access
- 1 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (2) , ytaa529
Abstract
Background: Cardiac involvement in Anderson–Fabry disease (AFD) can lead to arrhythmia, including ventricular tachycardia (VT). The literature on radiofrequency ablation (RFA) for the treatment of VT in AFD disease is limited.Case summary: We discuss RFA of drug-refractory VT electrical storm in three males with AFD. The first patient (53 years old) had extensive involvement of the inferolateral left ventricle (LV) demonstrated with cardiac magnetic resonance imaging (CMRI), with a left ventricular ejection fraction (LVEF) of 35%. Two VT ablation procedures were performed. At the first procedure, the inferobasal endocardial LV was ablated. Furthermore, VT prompted a second ablation, where epicardial and endocardial sites were ablated. The acute arrhythmia burden was controlled but he died 4 months later despite appropriate implantable cardioverter-defibrillator therapies for VT. The second patient (67 years old) had full-thickness inferolateral involvement demonstrated with CMRI and LVEF of 45%. RFA of several endocardial left ventricular sites was performed. Over a 3-year follow-up, only brief non-sustained VT was identified, but he subsequently died of cardiac failure. Our third patient (69 years old), had an LVEF of 35%. He had RFA of endocardial left ventricular apical disease, but died 3 weeks later of cardiac failure.Discussion: RFA of drug-refractory VT in AFD is feasible using standard electrophysiological mapping and ablation techniques, although the added clinical benefit is of questionable value. VT storm in the context of AFD may be a marker of end-stage disease.Keywords
This publication has 12 references indexed in Scilit:
- Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practiceEP Europace, 2017
- Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry CardiomyopathyThe American Journal of Cardiology, 2016
- Relation of Burden of Myocardial Fibrosis to Malignant Ventricular Arrhythmias and Outcomes in Fabry DiseaseThe American Journal of Cardiology, 2014
- Fabry Disease and Cardiovascular InvolvementCurrent Pharmaceutical Design, 2013
- Arrhythmias in Fabry CardiomyopathyClinical Cardiology, 2012
- Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry diseaseHeart Rhythm, 2011
- Catheter Ablation of Reentrant Left Ventricular Tachycardia Associated with Fabry disease: A Case ReportJournal of Arrhythmia, 2010
- Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardiaJournal of Cardiology, 2009
- Ventricular Tachycardias and Dilated Cardiomyopathy Caused by Fabry DiseasePacing and Clinical Electrophysiology, 2005
- The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the diseaseEuropean Heart Journal, 2005